V. Vendrely

8.8k total citations · 2 hit papers
161 papers, 3.4k citations indexed

About

V. Vendrely is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, V. Vendrely has authored 161 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Surgery, 101 papers in Oncology and 70 papers in Pulmonary and Respiratory Medicine. Recurrent topics in V. Vendrely's work include Colorectal and Anal Carcinomas (82 papers), Colorectal Cancer Surgical Treatments (64 papers) and Gastric Cancer Management and Outcomes (30 papers). V. Vendrely is often cited by papers focused on Colorectal and Anal Carcinomas (82 papers), Colorectal Cancer Surgical Treatments (64 papers) and Gastric Cancer Management and Outcomes (30 papers). V. Vendrely collaborates with scholars based in France, Canada and Italy. V. Vendrely's co-authors include Éric Rullier, Alexis Laurent, Anne Rullier, Quentin Denost, Olivier Bouché, Geneviève Belleannée, Pierre-Luc Etienne, Éric François, Paulette Bioulac‐Sage and F. Bretagnol and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

V. Vendrely

147 papers receiving 3.4k citations

Hit Papers

Comparison of Two Neoadjuvant Chemoradiotherapy Regimens ... 2010 2026 2015 2020 2010 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
    2010 537 citations D. Azria, V. Vendrely et al. Journal of Clinical Oncology profile →
  2. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial
    2024 57 citations V. Vendrely, Olivier Bouché et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Vendrely France 28 2.7k 2.1k 932 393 311 161 3.4k
Jerome C. Landry United States 34 1.8k 0.7× 1.5k 0.7× 1.3k 1.4× 584 1.5× 267 0.9× 115 3.3k
Lisa Sengeløv Denmark 19 1.4k 0.5× 2.1k 1.0× 1.1k 1.1× 417 1.1× 217 0.7× 45 3.5k
Seong Hyeon Yun South Korea 37 3.5k 1.3× 2.2k 1.1× 1.0k 1.1× 362 0.9× 324 1.0× 207 4.5k
Johanna W. Wilmink Netherlands 29 1.7k 0.6× 780 0.4× 829 0.9× 658 1.7× 278 0.9× 98 2.5k
K.K. Fu United States 18 1.1k 0.4× 1.4k 0.7× 917 1.0× 258 0.7× 214 0.7× 54 2.8k
Yuta Abe Japan 22 933 0.4× 974 0.5× 670 0.7× 325 0.8× 122 0.4× 139 2.2k
Tomomichi Kiyomatsu Japan 25 1.3k 0.5× 949 0.5× 507 0.5× 214 0.5× 135 0.4× 135 2.0k
Maurizio Cosimelli Italy 27 1.6k 0.6× 1.1k 0.5× 562 0.6× 228 0.6× 289 0.9× 103 2.5k
Shuichi Hironaka Japan 33 2.8k 1.0× 2.9k 1.4× 4.1k 4.4× 354 0.9× 241 0.8× 149 5.8k
Sung Whan Ha South Korea 29 892 0.3× 636 0.3× 724 0.8× 649 1.7× 248 0.8× 126 2.1k

Countries citing papers authored by V. Vendrely

Since Specialization
Citations

This map shows the geographic impact of V. Vendrely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Vendrely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Vendrely more than expected).

Fields of papers citing papers by V. Vendrely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Vendrely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Vendrely. The network helps show where V. Vendrely may publish in the future.

Co-authorship network of co-authors of V. Vendrely

This figure shows the co-authorship network connecting the top 25 collaborators of V. Vendrely. A scholar is included among the top collaborators of V. Vendrely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Vendrely. V. Vendrely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilbert, Alexandra, et al.. (2025). Treatment of anal cancer in older patients and patients with frailty. 100155–100155.
2.
Azria, D., et al.. (2024). Impact of discrimination on training and career of radiation oncologists in France. Clinical and Translational Radiation Oncology. 48. 100840–100840. 1 indexed citations
3.
Malicot, Karine Le, C. Lemanski, Emmanuel Deshayes, et al.. (2024). Prognostic Value of18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE. Journal of Nuclear Medicine. 65(8). 1194–1201. 1 indexed citations
4.
Lemanski, C., P. Pommier, Karine Le Malicot, et al.. (2024). Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE. British Journal of Cancer. 130(5). 769–776. 1 indexed citations
5.
6.
Laroche‐Clary, Audrey, Marie‐Alix Derieppe, V. Vendrely, et al.. (2023). Selective DNA-PK Inhibition Enhances Chemotherapy and Ionizing Radiation Activity in Soft-Tissue Sarcomas. Clinical Cancer Research. 30(3). 629–637. 4 indexed citations
7.
Borg, Christophe, V. Vendrely, Thierry André, et al.. (2023). 651P DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: A multicenter propensity score matching study. Annals of Oncology. 34. S456–S457. 1 indexed citations
8.
Adenis, Antoine, Guillaume Piessen, Samuel Le Sourd, et al.. (2023). Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT.. Journal of Clinical Oncology. 41(4_suppl). 370–370.
9.
Huguet, F., O. Riou, Dominique Pasquier, et al.. (2023). Radiation therapy of the primary tumour and/or metastases of digestive metastatic cancers. Cancer/Radiothérapie. 28(1). 66–74.
10.
Giraud, Nicolas, et al.. (2022). Préservation d’organe dans les cancers du rectum : quels arguments en faveur de la radiothérapie ?. Cancer/Radiothérapie. 26(6-7). 766–770.
11.
Denost, Quentin, V. Vendrely, Bertrand Célérier, et al.. (2021). Oncological strategy following R1 sphincter-saving resection in low rectal cancer after chemoradiotherapy. European Journal of Surgical Oncology. 47(7). 1683–1690. 5 indexed citations
12.
Garant, Aurélie, Petr Kavan, André‐Guy Martin, et al.. (2020). Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial. Radiotherapy and Oncology. 155. 237–245. 17 indexed citations
13.
Buscail, Étienne, Thomas Cauvin, Benjamı́n Fernández, et al.. (2019). Intraductal papillary mucinous neoplasms of the pancreas and European guidelines: importance of the surgery type in the decision-making process. BMC Surgery. 19(1). 115–115. 13 indexed citations
14.
Masson, Ingrid, G. Delpon, & V. Vendrely. (2018). Apport de la radiothérapie guidée par l’image et repositionnement du patient dans le cancer anorectal. Cancer/Radiothérapie. 22(6-7). 622–630. 3 indexed citations
15.
16.
Vendrely, V., Éric Rullier, P. Rouanet, et al.. (2014). Local Excision Versus Total Mesorectal Excision in Patients with Good Response After Neoadjuvant Radiochemotherapy for T2-T3 Low Rectal Cancer: Preliminary Results of the GRECCAR 2 Randomized Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 90(1). S20–S20. 10 indexed citations
17.
Denost, Quentin, Alexis Laurent, Jean‐Philippe Adam, et al.. (2013). Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head. HPB. 15(9). 716–723. 22 indexed citations
18.
Rullier, Éric, Quentin Denost, V. Vendrely, Anne Rullier, & Alexis Laurent. (2013). Low Rectal Cancer. Diseases of the Colon & Rectum. 56(5). 560–567. 158 indexed citations
19.
Rullier, Éric & V. Vendrely. (2011). Can mesorectal lymph node excision be avoided in rectal cancer surgery?. Colorectal Disease. 13(s7). 37–42. 9 indexed citations
20.
Rullier, Éric, Alexis Laurent, F. Bretagnol, et al.. (2005). Sphincter-Saving Resection for All Rectal Carcinomas. Annals of Surgery. 241(3). 465–469. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerome C. Landry Breakdown of academic impact, for papers by Lisa Sengeløv Breakdown of academic impact, for papers by Seong Hyeon Yun Breakdown of academic impact, for papers by Johanna W. Wilmink Breakdown of academic impact, for papers by K.K. Fu Breakdown of academic impact, for papers by Yuta Abe Breakdown of academic impact, for papers by Tomomichi Kiyomatsu Breakdown of academic impact, for papers by Maurizio Cosimelli Breakdown of academic impact, for papers by Shuichi Hironaka Breakdown of academic impact, for papers by Sung Whan Ha
Rankless by CCL
2026